Literature DB >> 22595805

Appropriateness for electroconvulsive therapy (ECT) can be assessed on a three-item scale.

Charles H Kellner1, Dennis M Popeo, Rosa M Pasculli, Mimi C Briggs, Stephen Gamss.   

Abstract

Electroconvulsive therapy (ECT) is the most effective and rapid treatment for severe depression; however, it should be prescribed to the limited number of patients with severe mood and psychotic disorders for whom it is clearly appropriate. We present an assessment scale that we hypothesize can be used to predict a patient's appropriateness for ECT, based on the severity, heritability, and episodic nature of their depression. This scale is offered as a tool to help the practitioner and patient gain a sense of how well the patient fits the profile of someone for whom ECT is a reasonable treatment option.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22595805     DOI: 10.1016/j.mehy.2012.04.036

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

Review 1.  On the significance of electroconvulsive therapy in the treatment of severe mental diseases.

Authors:  Michael Grözinger; Elke Stefanie Smith; Andreas Conca
Journal:  Wien Klin Wochenschr       Date:  2015-03-03       Impact factor: 1.704

2.  A functional MRI marker may predict the outcome of electroconvulsive therapy in severe and treatment-resistant depression.

Authors:  J A van Waarde; H S Scholte; L J B van Oudheusden; B Verwey; D Denys; G A van Wingen
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

Review 3.  Nonpharmacologic treatments for depression related to reproductive events.

Authors:  Anna R Brandon; Shannon K Crowley; Jennifer L Gordon; Susan S Girdler
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

4.  Effectiveness of electroconvulsive therapy in patients with "less treatment-resistant" depression by the Maudsley Staging Model.

Authors:  Yarong Ma; Robert Rosenheck; Biyu Ye; Ni Fan; Hongbo He
Journal:  Brain Behav       Date:  2020-05-13       Impact factor: 2.708

5.  Evidence for increased genetic risk load for major depression in patients assigned to electroconvulsive therapy.

Authors:  Jerome C Foo; Fabian Streit; Josef Frank; Stephanie H Witt; Jens Treutlein; Bernhard T Baune; Susanne Moebus; Karl-Heinz Jöckel; Andreas J Forstner; Markus M Nöthen; Marcella Rietschel; Alexander Sartorius; Laura Kranaster
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-12-02       Impact factor: 3.568

6.  'Treatment resistance' in electroconvulsive therapy (ECT) patients: time to move on.

Authors:  C H Kellner; A Nordenskjöld
Journal:  Acta Psychiatr Scand       Date:  2019-11       Impact factor: 6.392

7.  Electroconvulsive Therapy Pulse Amplitude and Clinical Outcomes.

Authors:  Christopher C Abbott; Davin Quinn; Jeremy Miller; Enstin Ye; Sulaiman Iqbal; Megan Lloyd; Thomas R Jones; Joel Upston; Zhi De Deng; Erik Erhardt; Shawn M McClintock
Journal:  Am J Geriatr Psychiatry       Date:  2020-06-17       Impact factor: 4.105

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.